TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,503,000 | +108.2% | 236,139 | +24.6% | 0.00% | +100.0% |
| Q1 2021 | $3,124,000 | +577.7% | 189,452 | +656.6% | 0.00% | – |
| Q4 2020 | $461,000 | +184.6% | 25,040 | +110.7% | 0.00% | – |
| Q3 2020 | $162,000 | -86.3% | 11,883 | -82.0% | 0.00% | -100.0% |
| Q2 2020 | $1,181,000 | +603.0% | 65,901 | +292.1% | 0.00% | – |
| Q1 2020 | $168,000 | +71.4% | 16,806 | +39.3% | 0.00% | – |
| Q4 2019 | $98,000 | -98.8% | 12,066 | -98.6% | 0.00% | -100.0% |
| Q3 2019 | $8,338,000 | +6734.4% | 841,436 | +8563.9% | 0.01% | – |
| Q2 2019 | $122,000 | +40.2% | 9,712 | +13.4% | 0.00% | – |
| Q1 2019 | $87,000 | +625.0% | 8,568 | +413.4% | 0.00% | – |
| Q4 2018 | $12,000 | -55.6% | 1,669 | -39.1% | 0.00% | – |
| Q3 2018 | $27,000 | -99.6% | 2,741 | -99.5% | 0.00% | -100.0% |
| Q2 2018 | $7,223,000 | – | 571,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |